Transcatheter aortic valve implantation in patient with critical aortic stenosis in the setting of cardiogenic shock
https://doi.org/10.18087/cardio.2021.1.n1010
Abstract
This article presents a clinical case of successful transcatheter aortic valve implantation in an elderly patient with critical aortic stenosis at the stage of systolic dysfunction with development of genuine cardiogenic shock. The role of transcatheter aortic valve implantation in the pathogenetic treatment of acute heart failure due to decompensated aortic stenosis was briefly discussed.
Keywords
About the Authors
A. E. KomlevRussian Federation
cardiologist, Department of cardiovascular surgery
T. E. Imaev
Russian Federation
PhD, MD, chief researcher, Department of cardiovascular surgery
Ch. N. Sharapudinova
Russian Federation
postgraduate resident, Department of emergent cardiology
A. S. Kolegaev
Russian Federation
PhD, researcher, Department of cardiovascular surgery
I. V. Kuchin
Russian Federation
cardiovascular surgeon, Department of cardiovascular surgery
D. V. Salichkin
Russian Federation
PhD, cardiovascular surgeon, Department of cardiovascular surgery
M. I. Makeev
Russian Federation
sonographer, Department of ultrasound examination
R. S. Akchurin
Russian Federation
MD, professor, academician of RAS, Head of Department of cardiovascular surgery
References
1. Harjola V-P, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock: Clinical picture and outcome of cardiogenic shock. European Journal of Heart Failure. 2015;17(5):501–9. DOI: 10.1002/ejhf.260
2. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. European Heart Journal. 2003;24(13):1231–43. DOI: 10.1016/S0195-668X(03)00201-X
3. Osnabrugge RLJ, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM et al. Aortic Stenosis in the Elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a metaanalysis and modeling study. Journal of the American College of Cardiology. 2013;62(11):1002–12. DOI: 10.1016/j.jacc.2013.05.015
4. Saia F, Marrozzini C, Ciuca C, Guastaroba P, Taglieri N, Palmerini T et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention. 2013;8(12):1388–97. DOI: 10.4244/EIJV8I12A212
5. Buchwald AB, Meyer T, Scholz K, Unterberg C, Schorn B. Efficacy of balloon valvuloplasty in patients with critical aortic stenosis and cardiogenic shock-the role of shock duration. Clinical Cardiology. 2001;24(3):214–8. DOI: 10.1002/clc.4960240308
6. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. New England Journal of Medicine. 2011;364(23):2187–98. DOI: 10.1056/NEJMoa1103510
7. Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM et al. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. Journal of the American College of Cardiology. 2015;66(2):113–21. DOI: 10.1016/j.jacc.2015.05.017
8. Authors/Task Force Members, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G et al. Guidelines on the management of valvular heart disease (version 2012). European Heart Journal. 2012;33(19):2451–96. DOI: 10.1093/eurheartj/ehs109
9. Ben-Dor I, Pichard AD, Satler LF, Goldstein SA, Syed AI, Gaglia MA et al. Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients. JACC: Cardiovascular Interventions. 2010;3(11):1150–6. DOI: 10.1016/j.jcin.2010.08.014
10. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2017;38(36):2739–91. DOI: 10.1093/eurheartj/ehx391
11. Huang J, Chen P, Hu X, Tang J, Fang Z. Aortic stenosis complicated by cardiogenic shock treated by transcatheter aortic valve replacement with extracorporeal membrane oxygenation: A case report. Medicine. 2018;97(33):e11900. DOI: 10.1097/MD.0000000000011900
12. D’Ancona G, Pasic M, Buz S, Drews T, Dreysse S, Kukucka M et al. Transapical transcatheter aortic valve replacement in patients with cardiogenic shock. Interactive CardioVascular and Thoracic Surgery. 2012;14(4):426–30. DOI: 10.1093/icvts/ivr095
13. Drews T, Pasic M, Buz S, d’Ancona G, Dreysse S, Kukucka M et al. Transcatheter Aortic Valve Implantation in Very High-Risk Patients with EuroSCORE of More Than 40%. The Annals of Thoracic Surgery. 2013;95(1):85–93. DOI: 10.1016/j.athoracsur.2012.08.055
14. Frerker C, Schewel J, Schlüter M, Schewel D, Ramadan H, Schmidt T et al. Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis. EuroIntervention. 2016;11(13):1530–6. DOI: 10.4244/EIJY15M03_03
Review
For citations:
Komlev A.E., Imaev T.E., Sharapudinova Ch.N., Kolegaev A.S., Kuchin I.V., Salichkin D.V., Makeev M.I., Akchurin R.S. Transcatheter aortic valve implantation in patient with critical aortic stenosis in the setting of cardiogenic shock. Kardiologiia. 2021;61(1):104-108. (In Russ.) https://doi.org/10.18087/cardio.2021.1.n1010